Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Justice

Showing results (481-490 of 587) with videos related to

Pageof 59
Sort By:
JAMA Network Open|December 14, 2022
Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus TreatmentLamia Y Haque, David A Fiellin, Janet P Tate, et al.
Open Forum Infectious Diseases|August 19, 2015
Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected PatientsVincent Lo Re, Michael J Kallan, Janet P Tate, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patientsKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
Contemporary Clinical Trials|May 25, 2023
Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trialE Jennifer Edelman, James Dziura, Yanhong Deng, et al.
Addiction (Abingdon, England)|June 3, 2011
Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western KenyaRebecca K Papas, John E Sidle, Benson N Gakinya, et al.
Addiction Science & Clinical Practice|July 31, 2020
Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trialE Jennifer Edelman, Stephen A Maisto, Nathan B Hansen, et al.
AIDS and Behavior|September 8, 2021
Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIVJessica J Wyse, Kathleen A McGinnis, E Jennifer Edelman, et al.
The Lancet. HIV|May 22, 2019
Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trialE Jennifer Edelman, Stephen A Maisto, Nathan B Hansen, et al.
Pharmacoepidemiology and Drug Safety|June 5, 2023
Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIVJessie Torgersen, Scott Akers, Yuankai Huo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2015
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort CollaborationMargaret T May, Amy C Justice, Kate Birnie, et al.
Pageof 59

Showing results (481-490 of 587) with videos related to

Sort By:
Pageof 59
JAMA Network Open|December 14, 2022
Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus TreatmentLamia Y Haque, David A Fiellin, Janet P Tate, et al.
Open Forum Infectious Diseases|August 19, 2015
Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected PatientsVincent Lo Re, Michael J Kallan, Janet P Tate, et al.
Hepatology (Baltimore, Md.)|May 26, 2017
FIB-4 stage of liver fibrosis predicts incident heart failure among HIV-infected and uninfected patientsKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
Contemporary Clinical Trials|May 25, 2023
Contingency management with stepped care for unhealthy alcohol use among individuals with HIV: Protocol for a randomized controlled trialE Jennifer Edelman, James Dziura, Yanhong Deng, et al.
Addiction (Abingdon, England)|June 3, 2011
Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western KenyaRebecca K Papas, John E Sidle, Benson N Gakinya, et al.
Addiction Science & Clinical Practice|July 31, 2020
Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trialE Jennifer Edelman, Stephen A Maisto, Nathan B Hansen, et al.
AIDS and Behavior|September 8, 2021
Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIVJessica J Wyse, Kathleen A McGinnis, E Jennifer Edelman, et al.
The Lancet. HIV|May 22, 2019
Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trialE Jennifer Edelman, Stephen A Maisto, Nathan B Hansen, et al.
Pharmacoepidemiology and Drug Safety|June 5, 2023
Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIVJessie Torgersen, Scott Akers, Yuankai Huo, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2015
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort CollaborationMargaret T May, Amy C Justice, Kate Birnie, et al.
Pageof 59